Form 605 Corporations Law Section 671B Notice of ceasing to be a substantial holder To: Company Name/Scheme STARPHARMA HOLDINGS LIMITED ACN/ARSN 078 532 180 1. Details of substantial holder (1) Name UBS Group AG and its related bodies corporate ACN/ARSN (if applicable): The holder...
Ceasing to be a substantial holder
Filed with ASX ·
6ix hasn’t read this filing yet.
Starpharma Holdings Limited on 6ix
Earlier from Starpharma
- Annual General Meeting 2026 Date
- Becoming a substantial holder
- S&P DJI Announces September 2026 Quarterly Rebalance
- FY26 Key Financial Results and Annual Report
- 2026 Appendix 4G and Corporate Governance Statement
Later from Starpharma
- Chair and Deputy Chair Appointments
- Notification of cessation of securities - SPL
- Application for quotation of securities - SPL
- Change of Director's Interest Notice - C Maley
- Notice of Annual General Meeting/Proxy Form
Follow Starpharma into a list and get an email when it puts out news.
Follow Starpharma